Predicted to enable oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Predicted to be active in lipid droplet. Orthologous to human SDR16C6P (short chain dehydrogenase/reductase family 16C member 6, pseudogene). [provided by Alliance of Genome Resources, Apr 2022]